Skip to main content
Equibles
RGNX $7.64 -4.86%
RGNX logo
RGNX · REGENXBIO Inc.
Track RGNX — free

Use RGNX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RGNX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.64 -0.39 (-4.86%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Nov 5, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about our ability to continue as a going concern within 12 months from the issuance date of our consolidated financial statements for the three and nine months ended September 30, 2026 included in this Quarterly Report on Form 10-Q.”
View the 10-Q filed Nov 5, 2026
Market Cap
$505.18M
Shares
66.12M
Volume · Nov 13 716.16K Avg daily vol (3M) 1.39M
All webcasts

Conference · 2026-11-11

REGENXBIO Inc. (RGNX) November 11, 2026 Conference

Concluded Nov 11, 2026
Nov 11, 2026
Period
2026-11-11
Runtime
—
Sources
0 artifacts

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. Event details are collected in one workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Company webcastOpen the original investor-relations page
Full-screen source Call document
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →